China’s drug industry pivots to AI-powered candidates to drive next wave of deals

The Chinese pharmaceutical industry is increasingly integrating artificial intelligence into drug discovery processes to drive future development and investment deals.

Firefly links to the original publisher. The summary above is AI-generated for orientation and may differ from the source. The “current rank score” decays over time so newer significant stories surface first.